Shareholding24 Jun 2026, 01:19 pm
Swapan Khandelwal Acquires 0.62% Stake in Goldline Pharma
AI Summary
Swapan Khandelwal, Promoter and Whole Time Director of Goldline Pharmaceutical Ltd, has acquired 60,000 equity shares, representing 0.62% of the total issued and paid-up share capital. The acquisition was made through open market purchases on June 22, 2026. Following this transaction, Khandelwal's total holding in the company increased to 29.27%. This disclosure is made pursuant to Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
Key Highlights
- Promoter acquired 60,000 shares via open market.
- Acquisition represents 0.62% of total share capital.
- Total promoter holding now stands at 29.27%.
- Disclosure filed under SEBI SAST Regulations, 2011.
Price Impact
More from GLPL